SCYNEXIS, Inc. to Present at the 29th Annual ROTH Conference

19:00 EST 6 Mar 2017 | Globe Newswire

JERSEY CITY, N.J., March 07, 2017 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (NASDAQ:SCYX) today announced that the Company will present at the 29th Annual ROTH Conference at the Ritz Carlton Laguna Niguel in Dana Point on Tuesday, March 14, 2017 at 5:30 p.m. PT.

A live webcast will be available on the Investors section of the Company's website: A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

SCYNEXIS is a drug development company committed to the development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. We are developing our lead product candidate, SCY-078, as an oral and IV drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. For more information, visit


Media Relations
Cammy Duong
MacDougall Biomedical Communications
Tel: 781.591.3443

Investor Relations
Susan Kim
Argot Partners
Tel: 212-203-4433

Primary Logo


More From BioPortfolio on "SCYNEXIS, Inc. to Present at the 29th Annual ROTH Conference"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...